Benzodiazepine toxicity
Important safety information
Flumazenil should only be administered by, or under the direct supervision of, personnel experienced in its use
NICE Guidance
NG225: Self-harm: assessment, management and preventing recurrence, September 2022
Flumazenil is a benzodiazepine antagonist for the reversal of the central sedative effects of benzodiazepines after anaesthetic and similar procedures. Flumazenil has a shorter half-life and duration of action than diazepam or midazolam so patients may become resedated
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary